Andrew O Westfall
Overview
Explore the profile of Andrew O Westfall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
4048
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Berg J, Gamarel K, Westfall A, Fortenberry J, Hosek S, Wilson C, et al.
J Adolesc Health
. 2020 Mar;
67(1):61-68.
PMID: 32169529
Purpose: HIV treatment as prevention is effective for reducing the risk of HIV transmission and the messaging campaign, undetectable = untransmittable, is gaining recognition. As youth living with HIV (YLWH)...
12.
Willig A, Webel A, Westfall A, Levitan E, Crane H, Buford T, et al.
Prog Cardiovasc Dis
. 2020 Feb;
63(2):170-177.
PMID: 32059838
Despite its potential to improve metabolic health outcomes, longitudinal physical activity (PA) patterns and their association with cardiometabolic disease among people living with HIV (PLWH) have not been well characterized....
13.
Gravett R, Westfall A, Overton E, Kudroff K, Muzny C, Eaton E
Int J STD AIDS
. 2020 Jan;
31(2):127-135.
PMID: 31992145
No abstract available.
14.
Hill S, Westfall A, Coyne-Beasley T, Simpson T, Elopre L
Sex Transm Dis
. 2020 Jan;
47(2):88-95.
PMID: 31934955
Background: Pre-exposure prophylaxis (PrEP) for individuals at significant risk for Human Immunodeficiency Virus acquisition is approved for individuals weighing at least 35 kg by the Food and Drug Administration. This...
15.
Sterrett S, Peng B, Burton R, LaFon D, Westfall A, Singh S, et al.
Vaccine
. 2020 Jan;
38(7):1778-1786.
PMID: 31911030
Background: PCV13 (conjugated polysaccharide) and PPSV23 (polysaccharide only) are two licensed vaccines targeting S. pneumoniae. The role of CD4 T-cell responses in pneumococcal vaccines among healthy participants and their impact...
16.
Cogliandro V, Yester D, Westfall A, Raper J, Saag M, Henostroza G, et al.
J Assoc Nurses AIDS Care
. 2019 Dec;
31(1):51-59.
PMID: 31869313
Bioelectrical impedance analysis phase angle (BIA-PA) is a valid indicator of mortality risk in people living with HIV; however, it is not known whether BIA-PA is valid for people living...
17.
Dionne-Odom J, Westfall A, Dombrowski J, Kitahata M, Crane H, Mugavero M, et al.
Clin Infect Dis
. 2019 Nov;
71(9):2405-2413.
PMID: 31712815
Background: Rates of early syphilis in US women are steadily increasing, but predictors of infection in this group are not clearly defined. Methods: This retrospective analysis focused on women enrolled...
18.
Zyambo C, Burkholder G, Cropsey K, Willig J, Wilson C, Gakumo C, et al.
BMC Public Health
. 2019 Oct;
19(1):1409.
PMID: 31664967
Background: People living with HIV (PLWH) have a high level of interest in quitting smoking, but only a small proportion have sustainable abstinence 6 months after cessation. Few investigations have...
19.
Batey D, Kay E, Westfall A, Zinski A, Drainoni M, Gardner L, et al.
AIDS Care
. 2019 Aug;
32(1):98-103.
PMID: 31462060
The literature recognizes six measures of retention in care, an integral component of the HIV Continuum of Care. Given prior research showing that different retention measures are differentially associated with...
20.
Lein Jr D, Willig J, Smith C, Curtis J, Westfall A, Hurt C
Gait Posture
. 2019 Aug;
73:246-250.
PMID: 31377580
Background: Clinicians often use thirty-second-sit (chair)-to-stand (30CST), timed-up-and-go (TUG), and the five-times-sit-to-stand (5xSTS) since these outcome measures (OMs) are sensitive for strength, balance and mobility. Research Question: The purpose of...